Table 5.
The association between CONUT score and clinicopathological features in patients with BTC.
| Factors | Studies(n) | OR(95%CI) | P | Heterogeneity I2(%) | Ph | Effects model |
|---|---|---|---|---|---|---|
| jaundice(yes vs no) | 2 | 1.60[1.14-2.25] | 0.006 | 0 | 0.43 | Fixed |
| degree of differentiation(poorly vs medium-high) | 3 | 1.43[1.03-1.99] | 0.03 | 0 | 0.38 | Fixed |
| pT stage (T3,4 vs T1,2) | 4 | 1.87[1.30-2.68] | 0.0007 | 0 | 0.70 | Fixed |
| complications (CD≥IIIa)(yes vs no) | 3 | 1.79[1.03-3.12] | 0.04 | 34 | 0.22 | Fixed |
CD, Clavien-Dindo classification.